Diabetes: Have we got it all wrong? Insulin hypersecretion and food additives: Cause of obesity and diabetes?

Diabetes Care

Volumn 35, Issue 12, 2012, Pages 2432-2437

  Corkey, Barbara E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANTIBIOTIC AGENT; BIPHENYL; DIAZOXIDE; INSULIN; IRON; MITOCHONDRIAL DNA; MONOACYLGLYCEROL; ORGANOCHLORINE PESTICIDE; PERCHLORATE; PERFLUORO COMPOUND; PHENOL DERIVATIVE; PHTHALIC ACID; POLYBROMINATED DIPHENYL ETHER; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; RIMONABANT; SWEETENING AGENT;

BYPASS SURGERY; DIABETES MELLITUS; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENZYME INHIBITION; EPIGENETICS; HUMAN; HUNGER; HYPERINSULINISM; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; KINESIOTHERAPY; LIPID STORAGE; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; POLLUTION; POLLUTION MONITORING; PREVALENCE; REVIEW; SATIETY;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FOOD ADDITIVES; HUMANS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL; OBESITY;

EID: 84869860002     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0825     Document Type: Review

References (61)

1. Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6-28 (Pubitemid 47229643)
2. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010;303:242-249
3. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249-1257
4. Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995;332:1210-1217
5. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577-1596
6. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 2011;95:875-892
7. Sims EA, Danforth E Jr, Horton ES, Glennon JA, Bray GA, Salans LB. Experimental obesity in man. A progress report. Isr J Med Sci 1972;8:813-814
8. Mann T, Tomiyama AJ, Westling E, Lew AM, Samuels B, Chatman J. Medicare's search for effective obesity treatments: diets are not the answer. Am Psychol 2007;62:220-233
9. Taubes G. Nutrition. The soft science of dietary fat. Science 2001;291:2536-2545
10. Corkey BE. Banting Lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 2012;61:4-13
11. th ed. New York, Random House Digital, Inc., 2009
12. Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ Health Perspect 2011;119:878-885
13. Hectors TL, Vanparys C, van der Ven K, et al. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia 2011;54:1273-1290
14. Alonso-Magdalena P, Quesada I, Nadal A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 2011;7:346-353
15. Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010;110:911-916.e12
16. Gloyn AL, Braun M, Rorsman P. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function. Diabetes 2009;58:800-802
17. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev 2007;29: 49-61 (Pubitemid 47229640)
18. Garland EJ, Remick RA, Zis AP. Weight gain with antidepressants and lithium. J Clin Psychopharmacol 1988;8:323-330
19. Debons AF, Siclari E, Das KC, Fuhr B. Gold thioglucose-induced hypothalamic damage, hyperphagia, and obesity: dependence on the adrenal gland. Endocrinology 1982;110:2024-2029
20. Farooqi IS, O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009;89:980S-984S
21. Nihalani N, Schwartz TL, Siddiqui UA, Megna JL. Weight gain, obesity, and psychotropic prescribing. J Obes 2011;2011: 893629
22. Kang JG, Park CY. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 2012;36:13-25
23. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes 2011;2011:179674
24. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010;57:359-372
25. Pories WJ, Dohm GL. Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 2012;35:2438-2442
26. Zigman JM, Nakano Y, Coppari R, et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 2005;115:3564-3572 (Pubitemid 43121844)
27. Phillips ML. Gut reaction: environmental effects on the human microbiota. Environ Health Perspect 2009;117:A198-A205
28. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 2011;18:139-143
29. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350:2549-2557 (Pubitemid 38758542)
30. Fisher-Wellman KH, Neufer PD. Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol Metab 2012;23:142-153
31. Newsholme P, Gaudel C, Krause M. Mitochondria and diabetes. An intriguing pathogenetic role. Adv Exp Med Biol 2012;942:235-247
32. Alcolado JC, Laji K, Gill-Randall R. Maternal transmission of diabetes. Diabet Med 2002;19:89-98 (Pubitemid 34225221)
33. Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 2010;5:297-348
34. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011;378:169-181
35. Villeneuve LM, Reddy MA, Natarajan R. Epigenetics: deciphering its role in diabetes and its chronic complications. Clin Exp Pharmacol Physiol 2011;38:401-409
36. Gavin JR 3rd, Roth J, Neville DM Jr, de Meyts P, Buell DN. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci USA 1974;71:84-88
37. Schwartz MW, Marks JL, Sipols AJ, et al. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991;128:2645-2647
38. ChavezM, Kaiyala K, Madden LJ, Schwartz MW, Woods SC. Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci 1995;109:528-531
39. Destefano MB, Stern JS, Castonguay TW. Effect of chronic insulin administration on food intake and body weight in rats. Physiol Behav 1991;50:801-806
40. Alemzadeh R, Jacobs W, Pitukcheewanont P. Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 1996;45:334-341 (Pubitemid 26102638)
41. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE. Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 1998;83: 1911-1915 (Pubitemid 28496315)
42. Standridge M, Alemzadeh R, Zemel M, Koontz J, Moustaid-Moussa N. Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. FASEB J 2000;14:455-460 (Pubitemid 30143164)
43. Saadeh M, Ferrante TC, Kane A, ShirihaiO, Corkey BE, Deeney JT. Reactive oxygen species stimulate insulin secretion in rat pancreatic islets: studies using monooleoyl-glycerol. PLoS ONE 2012;7: e30200
44. Alonso-Magdalena P, Ropero AB, Soriano S, et al. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways.Mol Cell Endocrinol 2012;355: 201-207
45. Persaud SJ, Al-Majed H, Raman A, Jones PM. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. J Endocrinol 1999;163: 207-212
46. Hoa NK, Norberg A, Sillard R, et al. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets. J Endocrinol 2007;192:389-394 (Pubitemid 46444440)
47. Szopa TM, Ward T, Dronfield DM, Portwood ND, Taylor KW. Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 1990;33:325-328 (Pubitemid 20189288)
48. Larue-Achagiotis C, Goubern M, Laury MC. Concomitant food intake and adipose tissue responses under chronic insulin infusion in rats. Physiol Behav 1988;44: 95-100
49. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994;37:1025-1035 (Pubitemid 24300460)
50. Fajans SS, Vinik AI. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am 1989;18:45-74 (Pubitemid 19058101)
51. Greenwood RH, Mahler RF, Hales CN. Improvement in insulin secretion in diabetes after diazoxide. Lancet 1976;1:444-447
52. Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000;49:2094-2101
53. Pories WJ, MacDonald KG Jr, Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992;55(Suppl.): 582S-585S
54. Pi J, Bai Y, Zhang Q, et al. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 2007;56:1783-1791 (Pubitemid 47025446)
55. Hoek JB, Rydström J. Physiological roles of nicotinamide nucleotide transhydrogenase. Biochem J 1988;254:1-10
56. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 2002;348:93-112 (Pubitemid 41103102)
57. Jones DP, Park Y, Gletsu-Miller N, et al. Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humans. Nutrition 2011;27: 199-205
58. Getty-Kaushik L, Richard AM, Deeney JT, Krawczyk S, Shirihai O, Corkey BE. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets. Obesity (Silver Spring) 2009;17: 1856-1860
59. Scheen AJ. The endocannabinoid system: a promising target for the management of type 2 diabetes. Curr Protein Pept Sci 2009;10:56-74
60. Fong TM, Heymsfield SB. Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions. Int J Obes (Lond) 2009;33:947-955
61. Corkey BE, Shirihai O. Metabolic master regulators: sharing information among multiple systems. Trends Endocrinol Metab. 30 August 2012 [Epub ahead of print]